42 studies found for:    PINK1
Show Display Options
Download search resultsDownload the search results for:
PINK1 (42 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Parkin Mutations and Their Functional Consequences
Condition: Parkinson's Disease
Intervention:
2 Unknown  Genetic Study in Young Onset Parkinson's Disease
Condition: Parkinson Disease
Intervention:
3 Unknown  Clinical, Molecular and by Neuroimaging of LRRK2 Mutations
Condition: Parkinson's Disease
Intervention:
4 Completed Loperamide Grapefruit Juice Interaction PK Trial
Condition: Drug Interaction
Interventions: Drug: Loperamide / Red Grapefruit Juice;   Drug: Loperamide/ White Grapefruit Juice;   Drug: Loperamide / Pink Grapefruit Juice
5 Active, not recruiting Esthetic, Clinical and Radiographic Outcomes of Immediately Placed Implants (Type 1) and Early Placed Implants (Type 2)
Conditions: Jaw, Edentulous, Partially;   Acquired Absence of Single Tooth
Intervention: Procedure: Placement of a dental implant
6 Recruiting A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors
Condition: Cancer
Interventions: Drug: Trametinib;   Drug: Palbociclib
7 Enrolling by invitation Case Selection and Treatment Protocol for Immediate Dental Implants in the Esthetic Zone
Conditions: Jaw, Edentulous, Partially;   Acquired Absence of Single Tooth
Intervention: Device: SLActive implant
8 Recruiting A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Dihydroartemisinin + Piperaquine tetraphosphate;   Drug: Artemether + Lumefantrine
9 Completed
Has Results
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
Condition: Bacterial Conjunctivitis
Interventions: Drug: AzaSite;   Other: Vehicle
10 Recruiting Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy
Condition: Type 2 Diabetes
Interventions: Drug: MP513;   Drug: Placebo
11 Completed
Has Results
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
Condition: Bacterial Conjunctivitis
Interventions: Drug: AzaSite;   Drug: Tobramycin
12 Completed Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
Condition: Hypertension
Interventions: Drug: Amlodipine+Rosuvastatin;   Drug: GSK3074477 FDC - 1;   Drug: GSK3074477 FDC - 2
13 Not yet recruiting Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Drug: Rilapladib 25 mg;   Drug: Rilapladib 250 mg;   Drug: Itraconazole
14 Not yet recruiting Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
Condition: Respiratory Disorders
Interventions: Drug: Candesartan Cilexetil in formulation 1;   Drug: Candesartan Cilexetil in formulation 2;   Drug: ATACAND
15 Completed Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
Condition: Hypertension
Interventions: Drug: Candesartan cilexetil (GW615775, Test formulation);   Drug: Candesartan cilexetil (Reference treatment)
16 Completed
Has Results
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
Condition: Breakthrough Bleeding
Interventions: Drug: DR-1031;   Drug: Seasonale®;   Drug: Portia®
17 Terminated Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Dexrazoxane hydrochloride
18 Terminated Pilot Study to Assess Safety and Feasibility of Resuscitation of Preterm Infants With Controlled Volume of Air/Oxygen
Condition: Resuscitation
Intervention: Procedure: Controlled tidal volume resuscitation
19 Completed Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
Condition: Hypertension
Interventions: Drug: Candesartan cilexetil (GW615775, Test formulation);   Drug: Candesartan cilexetil (Reference treatment)
20 Not yet recruiting Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Tafenoquine Placebo;   Drug: Chloroquine;   Drug: Primaquine;   Drug: Primaquine Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years